Cerêve Inc. has raised $38 million in its series B round. The Oakmont Pa.-based company has developed the Cerêve Sleep System, a device designed to reduce latency to stage 1 and stage 2 sleep for people with insomnia. KKR led the financing and existing shareholders include Versant Ventures, Arboretum Ventures and Partner Ventures.